about
Prevalence of antiplatelet therapy in patients with diabetes.Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.A critical dialogue: communicating with type 2 diabetes patients about cardiovascular riskUse of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in SpainWhole blood viscosity assessment issues III: Association with international normalized ratio and thrombocytopeniaAspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyThe cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.Older Adults Reporting More Diabetes Mellitus Care Have Greater 9-Year SurvivalEffect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL/6 miceEffects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitusIncreases in ambient particulate matter air pollution, acute changes in platelet function, and effect modification by aspirin and omega-3 fatty acids: A panel studyStandards of medical care in diabetes--2009.Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) studyAspirin use and risk of type 2 diabetes in apparently healthy men.Use of aspirin among diabetics in the primary prevention of cardiovascular disease: need for reliable randomized evidence and astute clinical judgment.Prescription of Aspirin for adults with Diabetes.Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.American College of Endocrinology Pre-Diabetes Consensus Conference: part two.Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs.ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.
P2860
Q24813940-0397D8C6-57CF-4270-894B-5289376CE19CQ24816911-3BC75262-7C45-40CD-8BB6-6604688B5D1CQ28219258-1C5DCF2A-FDE0-4A9A-9033-41269B072671Q28222880-987C1C4A-829F-4B70-AE96-E90138A7A4F8Q33401066-4B477B4F-92B9-4A59-9724-1249538BE214Q33501445-5C0BE524-57CA-414B-BE10-7D99B2A2513EQ35752598-DCEB4985-335B-4C2F-9FAC-B5667FD260D7Q35755253-B52059D1-FEE8-4CAB-91CA-07F493DD4276Q36295307-932FC599-D357-4B1D-9C9A-8D9417DECABAQ36396132-9DBCA235-5E5E-4A9C-9009-410D8ECF16F4Q36398301-8ED8BCCD-1FE0-42BB-8707-9211AF8A309EQ36930450-625D65AF-B1F3-4916-93ED-E62CEAA4DF01Q37033456-D5D41557-0C1C-4200-8EDA-278A0C144C4FQ37036416-05D2CC66-7738-4BD4-A11C-0C2D8F7E99BCQ37138843-629DEDAE-D8A1-4FAA-980C-089C5C2F82C5Q37145998-D20F9407-9648-46E7-A904-F44A776B7961Q37407452-3FC004EF-CAC5-4759-89BD-11CB8F60AC5CQ37409154-752756AA-47DA-48C7-95B4-11F2FAAE8226Q37428365-B29AB63F-1978-41F1-8DDC-A1695AD749DFQ37612293-758A01C7-2166-47C0-A628-03AC19F77B8CQ42711225-9787E4D3-798B-407E-9EF1-772BA89AF0A5Q42795171-95DC72DB-6050-4990-96BA-B17A925CC52CQ55266131-9B9FE7CD-CF1F-4148-8789-88A83FF606FB
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Aspirin therapy in diabetes
@ast
Aspirin therapy in diabetes
@en
Aspirin therapy in diabetes
@nl
type
label
Aspirin therapy in diabetes
@ast
Aspirin therapy in diabetes
@en
Aspirin therapy in diabetes
@nl
prefLabel
Aspirin therapy in diabetes
@ast
Aspirin therapy in diabetes
@en
Aspirin therapy in diabetes
@nl
P1433
P1476
Aspirin therapy in diabetes
@en
P2093
American Diabetes Association
John A Colwell
P356
10.2337/DIACARE.27.2007.S72
P407
P478
27 Suppl 1
P577
2004-01-01T00:00:00Z